(106)Ruthenium brachytherapy for ciliary recurrence with supraciliary effusion in retinoblastoma.
作者信息
Chhablani Jay, Romanzo Antonio, Balmer Aubin, Pica Alessia, Gaillard Marie-Claire, Cozza Raffaele, Moeckli Raphaël, Munier Francis L
机构信息
Vitreo-Retina Services, L V Prasad Eye Institute, Hyderabad, Andhra Pradesh, India.
出版信息
Ophthalmic Genet. 2010 Dec;31(4):190-2. doi: 10.3109/13816810.2010.499888. Epub 2010 Sep 1.
PURPOSE
A 2-year-old boy with syndromic bilateral retinoblastoma resulting from a (del(13)(q12.3q14.3)) developed a recurrent tumor measuring 2.3 X 2.3 mm at the ora serrata 15 months following last treatment.
METHODS
Ultrasound biomicroscopy (UBM) revealed a mass invading the ciliary body 6.6 mm in diameter associated with a localized supraciliary effusion.
RESULTS
Complete tumor regression was achieved 1 month after brachytherapy with a (106)Ruthenium plaque. There was no recurrence at 16 months.
CONCLUSION
This is the first clinical demonstration of supraciliary effusion in recurrent retinoblastoma. Brachytherapy appears to be effective in the treatment of this type of recurrence.
Zotero 插件